Mercaptopurine Monohydrate is a purine analog and antimetabolite immunosuppressant used to treat acute lymphoblastic leukemia and specific autoimmune conditions. By inhibiting DNA synthesis in rapidly… Read more
Mercaptopurine Monohydrate is a purine analog and antimetabolite immunosuppressant used to treat acute lymphoblastic leukemia and specific autoimmune conditions. By inhibiting DNA synthesis in rapidly dividing cells, this medication effectively controls cancer cell proliferation and suppresses immune responses. Pharmaceutical laboratories rely on accurate reference standards of the active pharmaceutical ingredient, as well as its related degradation products and synthetic by-products, to ensure rigorous quality control. This category provides essential materials, including pharmacopeial and non-pharmacopeial impurities such as 6,6'-sulfanediyldi-7H-purine and 6-mercaptopurine disulfide. These compounds are critical for impurity profiling, method development, and analytical testing during the validation of pharmaceutical formulations. Utilizing high-quality reference standards and stable isotope labelled compounds enables researchers to maintain precise analytical accuracy, confirm compound identity, and ensure regulatory compliance in the testing of drug products containing Mercaptopurine Monohydrate.